Myriad Women's Health

Foresight now offers >99% detection rate across all ethnicities for alpha thalassemia, a serious condition recognized in guidelines. This results in a 10x lower false negative rate compared to publicly available data from other labs! Learn more: https://bddy.me/3msJis4

Tune in for a special presentation tomorrow at NSGC 2020 highlighting AMPLIFY technology, the latest innovation in NIPS! Our very own Susan Hancock and Dale Muzzey will be presenting. https://bddy.me/2UN6EMT

Watch our short video to see how myGeneHistory can simplify cancer risk assessment and identify patients who may be appropriate for hereditary cancer testing. Sign up for myGeneHistory here: https://bddy.me/33100r2

NSGC 2020 is here! We are excited to see you all (virtually) this week! Check out 2 of our posters and don't forget to visit the @myriadgenetics booth to help us support our advocacy partners!

Join us & @BeBrightPink to take the pledge to Mask Up for Mammograms and put preventive care back on your to-do list! https://bddy.me/38SppH6

Prequel with AMPLIFY's validation paper has been accepted by Genetics in Medicine! Read the paper here and learn how Prequel with AMPLIFY raises the bar for NIPS: https://bddy.me/3ntRGHP

Dr. Ron Wapner’s recent article outlines the benefits of expanded carrier screening and potential gaps of limited screening protocols. Foresight Carrier Screen maximizes detection rates across ethnicities to minimize these gaps. Read the article here: https://bddy.me/2TamwbF

Prequel with AMPLIFY can now determine fetal sex of each individual twin, making us the only lab that can offer this with a <10% failure rate. In fact, Prequel delivers results to 99.9% of patients, even for those carrying twins. Learn more: https://bddy.me/37znPt9

Do you know your risk of breast cancer? This brief quiz will help you determine whether you should be further evaluated for Hereditary Breast and Ovarian Cancer syndrome: https://bddy.me/3dx4mdm

Tune into a special presentation today to learn about the role of genetic screening in your patient care. More info here: https://bddy.me/3nVmTF2

We are looking forward to today’s start of the 23rd Annual Premier Women's Healthcare Virtual Conference. Congrats on 40 years NPWH!

During Down Syndrome Awareness Month, we are reminded of the impact of noninvasive prenatal screening for our patients. Watch one family's story here: https://bddy.me/3lQjOEt #DownSyndromeAwareness @TheDSDN

The COVID-19 pandemic has disrupted cancer screenings leading to long-term consequences of delayed diagnoses. Join us & @BeBrightPink to take the pledge to Mask Up for Mammograms & put preventive care back on your to-do list! Pledge here: https://bddy.me/36YCKwD

October is Breast Cancer Awareness Month! Learn more about your family’s risk of hereditary cancer, take this short quiz today: https://bddy.me/3l7kFQD

Interested in learning more about our Myriad Complete Access Program? This video breaks it down for you.

Read our latest blog to find out why raising awareness for Tay-Sachs disease is so important for Evan's family: https://bddy.me/3mPAi0R

Discussing cost with your patients just got simpler. We provide transparent pricing through our cost estimates tool for all three of our products now! Learn more here: https://bddy.me/3mCUUcu

Most women are more likely to have noticeable symptoms for Ovarian Cancer in more advanced stages, but symptoms can also be present in early-stage ovarian cance...r as well. If you experience any of these symptoms for longer than two weeks, report them to your doctor or gynecologist immediately. Read more about FAQ's around #OvarianCancer here: https://bddy.me/2HaGJet See more

During Ovarian Cancer Awareness Month take 1 minute out of your month to find out your risk for hereditary cancer with our short quiz: https://bddy.me/35E3ule

September is Sickle Cell Awareness Month. Stay educated. Spread Awareness. Read our Q&A with Andrea Matthews, the founder of the Children’s Sickle Cell Foundation, Inc. here: https://bddy.me/3heb4oJ